loader
Please Wait
Applying Filters...

List of All Manufacturers & Suppliers for 761136 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2LUSPATERCEPT-AAMT

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : REBLOZYL

U.S.A
Boulder Peptide 2024
Not Confirmed
arrow

Brand Name : REBLOZYL

U.S.A
arrow
Boulder Peptide 2024
Not Confirmed

Celgene Corporation

Dosage Form : POWDER;SUBCUTANEOUS

Brand Name : REBLOZYL

Dosage Strength : 25MG/VIAL

Packaging :

Approval Date :

Application Number : 761136

Regulatory Info :

Registration Country : USA

blank

02

Brand Name : REBLOZYL

U.S.A
Boulder Peptide 2024
Not Confirmed
arrow

Brand Name : REBLOZYL

U.S.A
arrow
Boulder Peptide 2024
Not Confirmed

Celgene Corporation

Dosage Form : POWDER;SUBCUTANEOUS

Brand Name : REBLOZYL

Dosage Strength : 75MG/VIAL

Packaging :

Approval Date :

Application Number : 761136

Regulatory Info :

Registration Country : USA

blank